GRB7 and ovarian carcinoma: To address this gap, we conduct rigorous validation through in vitro experiments and use substantial datasets from TCGA, GTEx, CCLE, and GEO, allowing for a comprehensive examination of GRB7 expression patterns in ovarian cancer and their correlation with prognosis.